Trump's 100% Tariffs on Pharmaceuticals Raise Healthcare Concerns

President Trump's announcement of a 100% tariff on certain brand-name drugs has sparked concerns over rising healthcare costs and access to essential medicines. This decision could lead to increased prices for consumers and strain the healthcare system, affecting millions of Americans. While some drugmakers' shares have declined, exemptions for companies investing in the U.S. may alter market dynamics, making this a critical issue for the healthcare landscape.